Literature DB >> 27956708

Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans.

Lise Hafkenscheid1, Albert Bondt2,3, Hans U Scherer2, Tom W J Huizinga2, Manfred Wuhrer3, René E M Toes2, Yoann Rombouts2,3,4.   

Abstract

Recently, we showed the unexpectedly high abundance of N-linked glycans on the Fab-domain of Anti-Citrullinated Protein Antibodies (ACPA). As N-linked glycans can mediate a variety of biological functions, we now aimed at investigating the structural composition of the Fab-glycans of ACPA-IgG to better understand their mediated biological effects. ACPA-IgG and noncitrulline specific (control) IgG from plasma and/or synovial fluid of nine ACPA positive rheumatoid arthritis patients were affinity purified. The N-linked glycosylation of total, Fc and F(ab')2 fragments, as well as heavy and light chains of ACPA-IgG and control IgG were analyzed by UHPLC and MALDI-TOF mass spectrometry. The Fc-glycosylation of ACPA-IgG and IgG was analyzed at the glycopeptide level using LC-MS. The structural analyses revealed that ACPA-IgG molecules contain highly sialylated glycans in their Fab-domain. Importantly, Fab-glycans were estimated to be present on over 90% of ACPA-IgG, which is five times higher than in control IgG isolated from the same patients. This feature was more prominent on ACPA isolated from synovial fluid compared with peripheral blood. These observations provide the first evidence pointing to the ability of ACPA-IgG to mediate novel immunological activities, for example through binding specific lectins via hyper-sialylated Fab-glycans.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27956708      PMCID: PMC5294214          DOI: 10.1074/mcp.M116.062919

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  32 in total

Review 1.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

2.  Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

Authors:  Yoann Rombouts; Annemiek Willemze; Joyce J B C van Beers; Jing Shi; Priscilla F Kerkman; Linda van Toorn; George M C Janssen; Arnaud Zaldumbide; Rob C Hoeben; Ger J M Pruijn; André M Deelder; Gertjan Wolbink; Theo Rispens; Peter A van Veelen; Tom W J Huizinga; Manfred Wuhrer; Leendert A Trouw; Hans U Scherer; René E M Toes
Journal:  Ann Rheum Dis       Date:  2015-01-13       Impact factor: 19.103

Review 3.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

4.  Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides.

Authors:  Maurice H J Selman; Mahdi Hemayatkar; André M Deelder; Manfred Wuhrer
Journal:  Anal Chem       Date:  2011-03-02       Impact factor: 6.986

5.  Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.

Authors:  Maurice H J Selman; Rico J E Derks; Albert Bondt; Magnus Palmblad; Bart Schoenmaker; Carolien A M Koeleman; Fleur E van de Geijn; Radboud J E M Dolhain; André M Deelder; Manfred Wuhrer
Journal:  J Proteomics       Date:  2011-11-15       Impact factor: 4.044

6.  Fc-glycosylation of IgG1 is modulated by B-cell stimuli.

Authors:  Jun Wang; Crina I A Balog; Kathrin Stavenhagen; Carolien A M Koeleman; Hans Ulrich Scherer; Maurice H J Selman; André M Deelder; Tom W J Huizinga; René E M Toes; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

7.  Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum.

Authors:  H Ulrich Scherer; Jun Wang; René E M Toes; Diane van der Woude; Carolien A M Koeleman; Arjen R de Boer; Tom W J Huizinga; André M Deelder; Manfred Wuhrer
Journal:  Proteomics Clin Appl       Date:  2008-11-20       Impact factor: 3.494

8.  High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.

Authors:  Maja Pucić; Ana Knezević; Jana Vidic; Barbara Adamczyk; Mislav Novokmet; Ozren Polasek; Olga Gornik; Sandra Supraha-Goreta; Mark R Wormald; Irma Redzić; Harry Campbell; Alan Wright; Nicholas D Hastie; James F Wilson; Igor Rudan; Manfred Wuhrer; Pauline M Rudd; Djuro Josić; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2011-06-08       Impact factor: 5.911

9.  High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification.

Authors:  Karli R Reiding; Dennis Blank; Dennis M Kuijper; André M Deelder; Manfred Wuhrer
Journal:  Anal Chem       Date:  2014-05-28       Impact factor: 6.986

10.  Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.

Authors:  Zahra Sabouri; Peter Schofield; Keisuke Horikawa; Emily Spierings; David Kipling; Katrina L Randall; David Langley; Brendan Roome; Rodrigo Vazquez-Lombardi; Romain Rouet; Jana Hermes; Tyani D Chan; Robert Brink; Deborah K Dunn-Walters; Daniel Christ; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

View more
  32 in total

Review 1.  The current status of anti-citrullinated protein antibodies and citrullinated protein-reactive B cells in the pathogenesis of rheumatoid arthritis.

Authors:  Jia He; JiYu Ju; XiaoDong Wang
Journal:  Mol Biol Rep       Date:  2021-12-02       Impact factor: 2.316

2.  Glycosylation of Antigen-Specific Antibodies: Perspectives on Immunoglobulin G Glycosylation in Vaccination and Immunotherapy.

Authors:  Pranay Bharadwaj; Margaret E Ackerman
Journal:  Exp Suppl       Date:  2021

Review 3.  Micro-Heterogeneity of Antibody Molecules.

Authors:  Yusuke Mimura; Radka Saldova; Yuka Mimura-Kimura; Pauline M Rudd; Roy Jefferis
Journal:  Exp Suppl       Date:  2021

4.  Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.

Authors:  Caleigh Mandel-Brehm; Miriam L Fichtner; Ruoyi Jiang; Valerie J Winton; Sara E Vazquez; Minh C Pham; Kenneth B Hoehn; Neil L Kelleher; Richard J Nowak; Steven H Kleinstein; Michael R Wilson; Joseph L DeRisi; Kevin C O'Connor
Journal:  J Immunol       Date:  2021-09-20       Impact factor: 5.426

5.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 6.  The B cell response to citrullinated antigens in the development of rheumatoid arthritis.

Authors:  Hans Ulrich Scherer; Tom W J Huizinga; Gerhard Krönke; Georg Schett; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

Review 7.  The role of autoantibodies in the pathophysiology of rheumatoid arthritis.

Authors:  V F A M Derksen; T W J Huizinga; D van der Woude
Journal:  Semin Immunopathol       Date:  2017-04-27       Impact factor: 9.623

8.  H and L Chain Affinity Maturation and/or Fab N-Glycosylation Influence Immunoreactivity toward Neutrophil Extracellular Trap Antigens in Rheumatoid Arthritis Synovial B Cell Clones.

Authors:  Elisa Corsiero; Emanuela Carlotti; Lucas Jagemann; Mauro Perretti; Costantino Pitzalis; Michele Bombardieri
Journal:  J Immunol       Date:  2020-03-27       Impact factor: 5.422

Review 9.  B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells.

Authors:  Carlo G Bonasia; Wayel H Abdulahad; Abraham Rutgers; Peter Heeringa; Nicolaas A Bos
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

Review 10.  Complement in the Initiation and Evolution of Rheumatoid Arthritis.

Authors:  V Michael Holers; Nirmal K Banda
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.